Zimmer Biomet receives FDA clearance for OrthoGrid Hip AI 4.0
The AI-powered tool offers improved accuracy and real-time features for hip arthroplasty.
See the latest news and media coverage for Zimmer Biomet. We track all announcements, press releases, and industry mentions in real time, all in one place.
Orthopedic medical technology company
zimmerbiomet.comLast updated
In short: Zimmer Biomet reported strong Q1 2026 financial growth, secured new FDA clearances for AI and robotic systems, and underwent leadership transitions.
The AI-powered tool offers improved accuracy and real-time features for hip arthroplasty.
ROSA® Knee with OptimiZe™ named Best Healthcare Robotics Solution by MedTech Breakthrough Awards. Surgeons share experiences.
Net sales reach $2.087 billion, up 9.3%; adjusted EPS $2.09, up 15.5%. Updates full-year guidance higher.
Suketu Upadhyay departs; Paul Stellato named interim CFO. The company searches for a permanent successor.
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
Zimmer (ZBH) stock outlook includes analysis of growth opportunities ahead, AI expansion trends, market sentiment with daily trading insights and expert commentary. Zimmer Biomet Holdings...
Zimmer Biomet has secured 510(k) clearance from the FDA for an advanced version of its ROSA Shoulder System. The upgraded system includes improved robotically assisted...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...
Track Zimmer Biomet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Zimmer Biomet and other trending companies.